Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Annals of the New York Academy of Sciences
|
June 30, 2007
History of the discovery of the thymosins
Allan L Goldstein
Expert Opinion on Biological Therapy
|
July 15, 2015
Introduction for the Fourth International Symposium on Thymosins in Health and Disease
Enrico Garaci, Allan L Goldstein
Expert Opinion on Biological Therapy
|
April 23, 2004
Thymosins: chemistry and biological properties in health and disease
Allan L Goldstein, Mahnaz Badamchian
Expert Opinion on Biological Therapy
|
April 28, 2009
From lab to bedside: emerging clinical applications of thymosin alpha 1
Allan L Goldstein, Adam L Goldstein
Expert Opinion on Biological Therapy
|
June 23, 2015
Advances in the basic and clinical applications of thymosin β4
Allan L Goldstein, Hynda K Kleinman
International Immunopharmacology
|
December 29, 2022
Thymosin β4 and the anti-fibrotic switch
Hynda K Kleinman, Veronika Kulik, Allan L Goldstein
Trends in Molecular Medicine
|
August 16, 2005
Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues
Allan L Goldstein, Ewald Hannappel, Hynda K Kleinman
Annals of the New York Academy of Sciences
|
October 12, 2012
Development of an analytical HPLC methodology to study the effects of thymosin β4 on actin in sputum of cystic fibrosis patients
Mahnaz Badamchian, Ali A Damavandy, Allan L Goldstein
Chest
|
November 14, 2006
Thymosin beta4 sequesters actin in cystic fibrosis sputum and decreases sputum cohesivity in vitro
Bruce K Rubin, Arnon P Kater, Allan L Goldstein
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 25, 2010
Biological activities of thymosin beta4 defined by active sites in short peptide sequences
Gabriel Sosne, Ping Qiu, Allan L Goldstein, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Annals of the New York Academy of Sciences
|
June 30, 2007
History of the discovery of the thymosins
Allan L Goldstein
Expert Opinion on Biological Therapy
|
July 15, 2015
Introduction for the Fourth International Symposium on Thymosins in Health and Disease
Enrico Garaci, Allan L Goldstein
Expert Opinion on Biological Therapy
|
April 23, 2004
Thymosins: chemistry and biological properties in health and disease
Allan L Goldstein, Mahnaz Badamchian
Expert Opinion on Biological Therapy
|
April 28, 2009
From lab to bedside: emerging clinical applications of thymosin alpha 1
Allan L Goldstein, Adam L Goldstein
Expert Opinion on Biological Therapy
|
June 23, 2015
Advances in the basic and clinical applications of thymosin β4
Allan L Goldstein, Hynda K Kleinman
International Immunopharmacology
|
December 29, 2022
Thymosin β4 and the anti-fibrotic switch
Hynda K Kleinman, Veronika Kulik, Allan L Goldstein
Trends in Molecular Medicine
|
August 16, 2005
Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues
Allan L Goldstein, Ewald Hannappel, Hynda K Kleinman
Annals of the New York Academy of Sciences
|
October 12, 2012
Development of an analytical HPLC methodology to study the effects of thymosin β4 on actin in sputum of cystic fibrosis patients
Mahnaz Badamchian, Ali A Damavandy, Allan L Goldstein
Chest
|
November 14, 2006
Thymosin beta4 sequesters actin in cystic fibrosis sputum and decreases sputum cohesivity in vitro
Bruce K Rubin, Arnon P Kater, Allan L Goldstein
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 25, 2010
Biological activities of thymosin beta4 defined by active sites in short peptide sequences
Gabriel Sosne, Ping Qiu, Allan L Goldstein, et al.
Page
of 3